These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28890430)

  • 1. How to personalize ovarian stimulation in clinical practice.
    Sighinolfi G; Grisendi V; La Marca A
    J Turk Ger Gynecol Assoc; 2017 Sep; 18(3):148-153. PubMed ID: 28890430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualization of controlled ovarian stimulation in vitro fertilization using ovarian reserve markers.
    Grisendi V; La Marca A
    Minerva Ginecol; 2017 Jun; 69(3):250-258. PubMed ID: 28271699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice.
    La Marca A; Sunkara SK
    Hum Reprod Update; 2014; 20(1):124-40. PubMed ID: 24077980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
    Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
    Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
    Magnusson Å; Nilsson L; Oleröd G; Thurin-Kjellberg A; Bergh C
    Hum Reprod; 2017 Apr; 32(4):811-819. PubMed ID: 28175316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.
    Hamdine O; Eijkemans MJ; Lentjes EW; Torrance HL; Macklon NS; Fauser BC; Broekmans FJ
    Hum Reprod; 2015 Jan; 30(1):170-8. PubMed ID: 25355590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol.
    Schoolcraft W; Schlenker T; Gee M; Stevens J; Wagley L
    Fertil Steril; 1997 Jan; 67(1):93-7. PubMed ID: 8986690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction.
    La Marca A; D'Ippolito G
    Reprod Biomed Online; 2014 Feb; 28(2):183-90. PubMed ID: 24368127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevention of ovarian hyperstimulation syndrome.
    Corbett S; Shmorgun D; Claman P; ;
    J Obstet Gynaecol Can; 2014 Nov; 36(11):1024-1033. PubMed ID: 25574681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population.
    McIlveen M; Skull JD; Ledger WL
    Hum Reprod; 2007 Mar; 22(3):778-85. PubMed ID: 17114197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are we choosing the correct FSH starting dose during controlled ovarian stimulation for intrauterine insemination cycles? Potential application of a nomogram based on woman's age and markers of ovarian reserve.
    Di Paola R; Garzon S; Giuliani S; Laganà AS; Noventa M; Parissone F; Zorzi C; Raffaelli R; Ghezzi F; Franchi M; Zaffagnini S
    Arch Gynecol Obstet; 2018 Nov; 298(5):1029-1035. PubMed ID: 30242498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making IVF more effective through the evolution of prediction models: is prognosis the missing piece of the puzzle?
    Simopoulou M; Sfakianoudis K; Antoniou N; Maziotis E; Rapani A; Bakas P; Anifandis G; Kalampokas T; Bolaris S; Pantou A; Pantos K; Koutsilieris M
    Syst Biol Reprod Med; 2018 Oct; 64(5):305-323. PubMed ID: 30088950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial.
    Youssef MA; van Wely M; Al-Inany H; Madani T; Jahangiri N; Khodabakhshi S; Alhalabi M; Akhondi M; Ansaripour S; Tokhmechy R; Zarandi L; Rizk A; El-Mohamedy M; Shaeer E; Khattab M; Mochtar MH; van der Veen F
    Hum Reprod; 2017 Jan; 32(1):112-118. PubMed ID: 27836979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of tests predicting ovarian reserve and IVF outcome.
    Broekmans FJ; Kwee J; Hendriks DJ; Mol BW; Lambalk CB
    Hum Reprod Update; 2006; 12(6):685-718. PubMed ID: 16891297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of myo-inositol/di-chiro-inositol on markers of ovarian reserve in women with PCOS undergoing IVF/ICSI: A systematic review and meta-analysis.
    Bhide P; Pundir J; Gudi A; Shah A; Homburg R; Acharya G
    Acta Obstet Gynecol Scand; 2019 Oct; 98(10):1235-1244. PubMed ID: 30993683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
    Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
    Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of ovarian reserve markers in smoking and non-smoking women undergoing IVF.
    Freour T; Dessolle L; Jean M; Masson D; Barriere P
    Reprod Biomed Online; 2010 Jun; 20(6):857-60. PubMed ID: 20382079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.